A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...
C3G and IC-MPGN both cause protein deposits that reduce kidney function. Overactive proteins in the immune system lead to these different conditions. C3G and IC-MPGN are rare kidney conditions. They ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most ...
Pegcetacoplan is the first FDA-approved treatment for C3G and primary IC-MPGN, targeting excessive C3 complement activation. The phase 3 VALIANT trial showed a 68% reduction in UPCR and stabilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback